Related Experiment Videos
Elevated adenosine 3',5'-cyclic monophosphate levels in human and animal tumors in vivo
Journal of the National Cancer Institute
|July 1, 1976
Abstract:
Cyclic AMP (cAMP) levels were measured in several animal and human tumors and in normal human tissues. Malignant tissues did not appear to be deficient in cAMP.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.
Bone marrow transplantation·2009
Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation·2007
Prophylactic cranial irradiation in small-cell lung cancer.
The oncologist·2000
Effects of 4-hydroxynonenal and N-acetyl-L-cysteine on Myc-induced apoptosis.
Toxicology letters·1996
High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide.
Journal of chromatography. B, Biomedical applications·1996
Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.
Journal of the National Cancer Institute·2026
Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study.
Journal of the National Cancer Institute·2026
Novel framework for the validation of intermediate clinical endpoints in oncology real-world data.
Journal of the National Cancer Institute·2026
Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study.
Journal of the National Cancer Institute·2026
Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
Journal of the National Cancer Institute·2026
Opioid Prescribing Changes in Advanced Cancer Before and After Withdrawal of Hydromorphone Slow-Release Tablets.
Asia-Pacific journal of clinical oncology·2026